Avacopan
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 280 publications
Damaged glomeruli in proliferative pediatric lupus nephritis exhibit a C5a-C5aR1 induced fibrotic transcriptional program.
Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026
Extrarenal Disease in ANCA-Associated Vasculitis: Challenges and Evolving Therapeutic Strategies on behalf of the Immunonephrology Working Group (IWG) of the ERA.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: March 31, 2026
Advances in the treatment of antineutrophil cytoplasmic antibody associated vasculitis: current recommendations, clinical trials and real word data.
Journal: Polish archives of internal medicine
Published: March 12, 2026
Systemic vasculitis: one year in review 2026.
Journal: Clinical and experimental rheumatology
Published: February 27, 2026
Regression of a Refractory Pulmonary Lesion in Granulomatosis with Polyangiitis Following the Addition of Avacopan.
Journal: European journal of rheumatology
Published: February 27, 2026
Practical Considerations for Infection Prevention with the Clinical Use of Complement Inhibitors.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: February 06, 2026
The free fatty acid 2 receptor regulates C5a induced neutrophil superoxide production and its sensitivity to inhibition by the antagonist avacopan.
Journal: Frontiers in immunology
Published: January 25, 2026
Selective Complement Inhibition in Anti-p200 Pemphigoid: Immune Infiltrate Profiles and Therapeutic Implications Compared to Bullous Pemphigoid.
Journal: Biomolecules
Published: January 06, 2026
Complement and inflammasome crosstalk in chronic inflammation.
Journal: Frontiers in immunology
Published: December 31, 2025
Update on antineutrophil cytoplasmic antibody vasculitis.
Journal: Current opinion in nephrology and hypertension
Published: December 29, 2025
Correction: Efficacy and safety of avacopan in the treatment of ANCA-associated vasculitis: a systematic review and meta-analysis.
Journal: BMC rheumatology
Published: December 24, 2025
Predictors of glucocorticoid-free clinical remission in patients with newly diagnosed microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study using a nationwide registry in Japan (J-CANVAS).
Journal: Arthritis research & therapy
Published: November 29, 2025
Last Updated: 04/28/2026